Effect of doravirine on dolutegravir trough concentrations in people with HIV switched from darunavir/cobicistat

J Antimicrob Chemother. 2023 Jun 1;78(6):1547-1548. doi: 10.1093/jac/dkad100.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Cobicistat / therapeutic use
  • Darunavir / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Pyridones / therapeutic use

Substances

  • dolutegravir
  • Darunavir
  • doravirine
  • Cobicistat
  • Pyridones
  • Anti-HIV Agents